Steven Katz, MD
Surgical Oncology · Providence, RINPI 1275793044
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $458,370 of the $498,985 with a category attached, or 91.9%. Trisalus Life Sciences, Inc. accounts for 99.1% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $363,736 and has fallen 100.0% since, to $145 in 2024.
Across 126 payments — averaging $3960.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trisalus Life Sciences, Inc.$494K
- Takeda Pharmaceutical Company, Limited$4K
- Medtronic$145
- Sirtex Medical Inc$40
Across 28 payments — averaging $27,174 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Trisalus Life Sciences, Inc.$714K
- Clinigen, Inc.$47K
What the payments were for
- Consulting fees$458,37092%
- Travel & lodging$28,3136%
- Food & beverage$7,1051%
- Education$5,1971%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trisalus Life Sciences, Inc. | 120 | $494,392 |
| Takeda Pharmaceutical Company, Limited | 3 | $4,408 |
| Medtronic | 2 | $145 |
| Sirtex Medical Inc | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Precision Infusion System$492,105
- ENDO GIA ULTRA$125
How this compares
Too few surgical oncology providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Providence
- Rachel BeardProvidence$19K
- Abdul Saied CalvinoProvidence$18K
- Timothy MurthaProvidence$5K
- Carl WinklerProvidence$654
- Michael TolkaczProvidence$197
- Micaela WeaverProvidence$66
- Charu TanejaProvidence$0
- Jamie PattersonWarwick$945
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.